 |
|
Influence of P53 on the radiotherapy response of hepatocellular carcinoma
Ana R. Gomes, Ana M. Abrantes, Ana F. Brito, Mafalda Laranjo, João E. Casalta-Lopes, Ana C. Gonçalves, Ana B. Sarmento-Ribeiro, Maria F. Botelho, José G. Tralhão
Clin Mol Hepatol. 2015;21(3):257-267. Published online 2015 Sep 30 DOI: https://doi.org/10.3350/cmh.2015.21.3.257
|
|
Citations to this article as recorded by
 Advances in radiotherapy and immunity in hepatocellular carcinoma
Yuhan Yang, Liting Xiong, Mengyuan Li, Ping Jiang, Junjie Wang, Chunxiao Li
Journal of Translational Medicine.2023;[Epub] CrossRef Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity
Shirley Lewis, Laura Dawson, Aisling Barry, Teodor Stanescu, Issa Mohamad, Ali Hosni
JHEP Reports.2022; 4(8): 100498. CrossRef Radiation Response of Human Leukemia/Lymphoma Cells was Improved by 7-Geranyloxycoumarin
Ramin Bagheri, Fatemeh B. Rassouli, Hamid Gholamhosseinian, Keyhan Ebrahimi, Shakiba Mahdavi, Sajad Goudarzi, Mehrdad Iranshahi, Houshang Rafatpanah, Mohammad Reza Keramati
Dose-Response.2022; 20(3): 155932582211244. CrossRef Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches
Zahra Farzaneh, Massoud Vosough, Tarun Agarwal, Maryam Farzaneh
Cancer Cell International.2021;[Epub] CrossRef In Vitro Cell Toxicity and Intracellular Uptake of Doxorubicin Exposed as a Solution or Liposomes: Implications for Treatment of Hepatocellular Carcinoma
Fredrik Kullenberg, Oliver Degerstedt, Carlemi Calitz, Nataša Pavlović, David Balgoma, Johan Gråsjö, Erik Sjögren, Mikael Hedeland, Femke Heindryckx, Hans Lennernäs
Cells.2021; 10(7): 1717. CrossRef Crosstalk between ER-stress and apoptosis in irradiated HepG2 cells with gemcitabine: implication of PI3K/AKT and IκB/NF-κB signaling pathways
Enas Mahmoud Moustafa, Laila Ahmed Rashed, Mohammed M. El-Sebaie, Noura Magdy Thabet, Mohamed Khairy Abdel-Rafei
Journal of Radiation Research and Applied Sciences.2020; 13(1): 144. CrossRef Metals and low dose IR: Molecular effects of combined exposures using HepG2 cells as a biological model
A. Campos, R. Pereira, A. Vaz, T. Caetano, M. Malta, J. Oliveira, F.P. Carvalho, S. Mendo, J. Lourenço
Journal of Hazardous Materials.2020; 396: 122634. CrossRef Proton Beam Induces P53-mediated Cell Cycle Arrest in HepG2 Hepatocellular Carcinoma Cells
So-Young Chun, Kyung-Soo Nam, Kyu-Shik Lee
Biotechnology and Bioprocess Engineering.2020; 25(2): 141. CrossRef β-radiating radionuclides in cancer treatment, novel insight into promising approach
Samieh Asadian, Hamed Mirzaei, Bagher Aziz Kalantari, Mohamad Reza Davarpanah, Morteza Mohamadi, Anastasia Shpichka, Leila Nasehi, Hamidreza Aboulkheyr Es, Peter Timashev, Mustapha Najimi, Nematollah Gheibi, Moustapha Hassan, Massoud Vosough
Pharmacological Research.2020; 160: 105070. CrossRef ZFP36 Binds With PRC1 to Inhibit Tumor Growth and Increase 5-Fu Chemosensitivity of Hepatocellular Carcinoma
Weiqian Chen, Minjiang Chen, Zhongwei Zhao, Qiaoyou Weng, Jingjing Song, Shiji Fang, Xulu Wu, Hailin Wang, Dengke Zhang, Weibin Yang, Zufei Wang, Min Xu, Jiansong Ji
Frontiers in Molecular Biosciences.2020;[Epub] CrossRef Iodine‑131 metabolic radiotherapy leads to cell death and genomic alterations through NIS overexpression on cholangiocarcinoma
Ana Brito, Ana Abrantes, Ricardo Teixo, Ana Pires, Ana Ribeiro, Rafael Ferreira, Alexandra Fernandes, Tiago Puga, Mafalda Laranjo, Francisco Caramelo, Ilka Boin, Douglas Jefferson, Ana Gon�alves, Ricardo Martins, Joana Rodrigues, Ilda Ribe
International Journal of Oncology.2020;[Epub] CrossRef HNF4α regulates sulfur amino acid metabolism and confers sensitivity to methionine restriction in liver cancer
Qing Xu, Yuanyuan Li, Xia Gao, Kai Kang, Jason G. Williams, Lingfeng Tong, Juan Liu, Ming Ji, Leesa J. Deterding, Xuemei Tong, Jason W. Locasale, Leping Li, Igor Shats, Xiaoling Li
Nature Communications.2020;[Epub] CrossRef The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformation
Melanie Dzulko, Miriam Pons, Andreas Henke, Günter Schneider, Oliver H. Krämer
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer.2020; 1874(2): 188453. CrossRef Lipoproteins-Nanocarriers as a Promising Approach for Targeting Liver Cancer: Present Status and Application Prospects
Saleh A. Alanazi, Fars Alanazi, Nazrul Haq, Faiyaz Shakeel, Mohamed M. Badran, Gamaleldin I. Harisa
Current Drug Delivery.2020; 17(10): 826. CrossRef PACT cessation overcomes ovarian cancer cell chemoresistance to cisplatin by enhancing p53-mediated apoptotic pathway
Xuemei Yang, Qian Zhang, Xiaofeng Yang, Minyi Zhao, Ting Yang, Anmei Yao, Xiaofei Tian
Biochemical and Biophysical Research Communications.2019; 511(4): 719. CrossRef Growth arrest-specific gene 2 suppresses hepatocarcinogenesis by intervention of cell cycle and p53-dependent apoptosis
Ran-Xu Zhu, Alfred Sze Lok Cheng, Henry Lik Yuen Chan, Dong-Ye Yang, Wai-Kay Seto
World Journal of Gastroenterology.2019; 25(32): 4715. CrossRef Growth arrest-specific gene 2 suppresses hepatocarcinogenesis by intervention of cell cycle and p53-dependent apoptosis
Ran-Xu Zhu, Alfred Sze Lok Cheng, Henry Lik Yuen Chan, Dong-Ye Yang, Wai-Kay Seto
World Journal of Gastroenterology.2019; 25(32): 4673. CrossRef Adenosine deaminase acting on RNA-1 (ADAR1) inhibits hepatitis B virus (HBV) replication by enhancing microRNA-122 processing
Guangyan Liu, Xiancai Ma, Zhe Wang, Kousho Wakae, Yaochang Yuan, Zhangping He, Hironori Yoshiyama, Hisashi Iizasa, Hui Zhang, Mami Matsuda, Ryuichi Sugiyama, Zhiyu Yuan, Masamichi Muramatsu, Linghua Li
Journal of Biological Chemistry.2019; 294(38): 14043. CrossRef Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review
Saleh Daher, Muhammad Massarwa, Ariel A. Benson, Tawfik Khoury
Journal of Clinical and Translational Hepatology.2018; 6(1): 1. CrossRef MDM2-p53 Interactions in Human Hepatocellular Carcinoma: What Is the Role of Nutlins and New Therapeutic Options?
Samy Azer
Journal of Clinical Medicine.2018; 7(4): 64. CrossRef Differential Radiation Sensitivity in p53 Wild-Type and p53-Deficient Tumor Cells Associated with Senescence but not Apoptosis or (Nonprotective) Autophagy
Jingwen Xu, Nipa H. Patel, Tareq Saleh, Emmanuel K. Cudjoe, Moureq Alotaibi, Yingliang Wu, Santiago Lima, Adam M. Hawkridge, David A. Gewirtz
Radiation Research.2018; 190(5): 538. CrossRef CMA down-regulates p53 expression through degradation of HMGB1 protein to inhibit irradiation-triggered apoptosis in hepatocellular carcinoma
Jing-Hua Wu, Jia-Pei Guo, Jun Shi, Hui Wang, Lei-Lei Li, Bin Guo, Dian-Xing Liu, Qing Cao, Zhi-Yong Yuan
World Journal of Gastroenterology.2017; 23(13): 2308. CrossRef Oxidative Stress, DNA, Cell Cycle/Cell Cycle Associated Proteins and Multidrug Resistance Proteins: Targets of Human Amniotic Membrane in Hepatocellular Carcinoma
A. C. Mamede, S. Guerra, M. Laranjo, K. Santos, M. J. Carvalho, T. Carvalheiro, P. Moura, A. Paiva, A. M. Abrantes, C. J. Maia, M. F. Botelho
Pathology & Oncology Research.2016; 22(4): 689. CrossRef High dose and compartmental target volume may improve patient outcome after radiotherapy for pelvic bone metastases from hepatocellular carcinoma
Taehyung Kim, Hye Jung Cha, Jun Won Kim, Jinsil Seong, Ik Jae Lee
Oncotarget.2016; 7(33): 53921. CrossRef Selective cytotoxicity and cell death induced by human amniotic membrane in hepatocellular carcinoma
A. C. Mamede, S. Guerra, M. Laranjo, M. J. Carvalho, R. C. Oliveira, A. C. Gonçalves, R. Alves, L. Prado Castro, A. B. Sarmento-Ribeiro, P. Moura, A. M. Abrantes, C. J. Maia, M. F. Botelho
Medical Oncology.2015;[Epub] CrossRef
|